bpc-157 news today fda reviews BPC-157, TB-500 and other peptides favored by RFK Jr FDA panel backs broader access
FDA panel backs broader access to BPC 157, opening scrutiny on peptide market Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for BREAKING: The peptide landscape just changed. The FDA advisory panel voted to recommend broader pharmacy compounding access for BPC 157, KPV, and TB 500. It's one of the biggest regulatory developments the peptide space FDA may take an important step toward opening the peptide floodgates this week
Pay in 4 interest-free payments of $6.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
